What is the management of Rhabdomyolysis (muscle breakdown disease)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Rhabdomyolysis

Immediately initiate aggressive intravenous fluid resuscitation with isotonic saline targeting urine output of at least 300 mL/hour, while simultaneously discontinuing any causative agents and monitoring for life-threatening hyperkalemia. 1, 2, 3

Immediate Actions and Initial Assessment

Discontinue Causative Agents

  • Stop all potentially offending medications immediately, including statins, fibrates, red yeast rice containing lovastatin, creatine monohydrate, wormwood oil, licorice, and Hydroxycut 1, 4
  • Avoid succinylcholine in any patient with suspected or confirmed rhabdomyolysis due to risk of severe hyperkalemia and cardiac arrest 5, 1
  • Review all over-the-counter medications, herbal supplements, performance-enhancing products, and recreational drugs (cocaine, methamphetamine, MDMA, ketamine, heroin) 1

Obtain Immediate Laboratory Testing

  • Creatine kinase (CK) is diagnostic when ≥5-10 times upper limit of normal (typically >1,000 U/L, with severe disease >50,000 U/L) 2, 3, 6
  • Comprehensive metabolic panel including creatinine, BUN, electrolytes (especially potassium), glucose, calcium, and phosphorus 2
  • Potassium level must be checked immediately as hyperkalemia can precipitate life-threatening cardiac arrhythmias and arrest 1, 2, 6
  • Urinalysis for myoglobinuria (brown/dark urine positive for blood without RBCs present) 2, 3
  • Arterial blood gas to assess for metabolic acidosis 1, 2
  • ECG immediately to assess for arrhythmias related to hyperkalemia 2
  • Cardiac troponin in severe cases to rule out cardiac involvement 2

Fluid Resuscitation Protocol

Volume and Rate

  • For severe rhabdomyolysis (CK >50,000 IU/L or >15,000 IU/L with renal dysfunction): administer >6L of isotonic saline per day 1, 2, 4
  • For moderate rhabdomyolysis (CK 15,000-50,000 IU/L): administer 3-6L of isotonic saline per day 1, 2
  • Target urine output of ≥300 mL/hour to prevent myoglobin-induced acute kidney injury 1, 4, 3, 6
  • Use isotonic saline (0.9% NaCl) as the initial fluid of choice; avoid hypotonic solutions like Ringer's lactate if head trauma is present 1

Duration of Therapy

  • Continue IV fluids until CK decreases to <1,000 U/L 2, 6
  • Early initiation of fluid resuscitation is critical, as delayed treatment significantly increases risk of acute kidney injury 1

Common Pitfall

  • Do not wait for creatinine elevation to 1.5 mg/dL before initiating aggressive fluid therapy—this threshold is specific to cirrhotic patients and does not apply to rhabdomyolysis 1

Electrolyte Management

Hyperkalemia (Life-Threatening Priority)

  • Monitor potassium every 6-12 hours in severe cases and correct emergently if elevated 1, 2
  • Hyperkalemia can precipitate cardiac arrhythmias and cardiac arrest, requiring immediate treatment 1, 2, 4

Other Electrolyte Abnormalities

  • Monitor and correct hypocalcemia, hyperphosphatemia, and hypomagnesemia 2
  • Assess for metabolic acidosis and treat accordingly 2, 3

Monitoring During Treatment

Serial Laboratory Assessment

  • Trend CK, creatinine, and electrolytes daily until CK is declining and renal function is stable 1, 2
  • Check electrolytes (particularly potassium) every 6-12 hours in severe cases 2
  • Monitor renal function (creatinine and BUN) daily until stable 2
  • Monitor urine output hourly with target ≥300 mL/hour 2

Compartment Syndrome Surveillance

  • Early signs include pain, tension, paresthesia, and paresis; late signs include pulselessness and pallor (often indicating irreversible damage) 1, 4
  • Consider fasciotomy when compartment pressure exceeds 30 mmHg or when differential pressure (diastolic BP minus compartment pressure) is <30 mmHg 1
  • Early fasciotomy is indicated for established compartment syndrome 1

Pain Management

First-Line Approach

  • Acetaminophen 500-1000 mg is the preferred initial analgesic (onset 15-30 minutes, maximum 4-6 grams daily) as it avoids nephrotoxic effects 1

Agents to Avoid

  • All NSAIDs (ibuprofen, ketoprofen, diclofenac, naproxen, mefenamic acid) must be avoided due to gastrointestinal and renal toxicity in patients already at high risk for acute kidney injury 1

Severe Pain Management

  • Reserve opioids for severe muscle pain unresponsive to acetaminophen 1
  • Oral morphine 20-40 mg is first-line for opioid-naive patients with severe pain 1
  • In patients with established AKI (eGFR <30 mL/min), use fentanyl or buprenorphine as the safest opioid choices 1

Severity Stratification

Mild Rhabdomyolysis

  • CK elevation <15,000 IU/L with normal renal function and no significant electrolyte abnormalities 2

Moderate Rhabdomyolysis

  • CK 15,000-50,000 IU/L with mild renal dysfunction, requiring 3-6L fluid resuscitation per day 2

Severe Rhabdomyolysis

  • CK >50,000 IU/L with acute kidney injury, requiring >6L fluid resuscitation per day and carrying high risk for complications including renal failure, severe electrolyte derangements, compartment syndrome, and disseminated intravascular coagulation 2, 3, 7

Etiology-Specific Considerations

Drug-Induced Rhabdomyolysis

  • For statin-induced cases, discontinue statin immediately and evaluate CK, creatinine, and urinalysis for myoglobinuria 1
  • Consider alternative lipid-lowering strategies: pravastatin or fluvastatin (minimal CYP450 metabolism), ezetimibe, PCSK9 inhibitors, or bempedoic acid 1, 4
  • Never combine gemfibrozil with any statin due to 10-fold higher rhabdomyolysis risk compared to fenofibrate 1
  • SLCO1B1 gene mutations increase risk of statin-induced rhabdomyolysis 1

Exertional Rhabdomyolysis

  • Properly calibrate training and conditioning sessions, especially during transition periods (returning after injury) 1, 4
  • Maintain adequate hydration throughout exercise and perioperative periods 1, 4

Trauma-Related Rhabdomyolysis

  • Crush injuries and severe limb trauma are major risk factors 1
  • Note that simple contusion from falls can elevate CK without true muscle breakdown; CK peaks 24-120 hours post-trauma, so repeat measurement at 24 hours if clinical suspicion remains high 1

Recurrent or Unexplained Cases

  • Consider genetic testing including RYR1 and CACNA1S gene sequencing for malignant hyperthermia susceptibility 1
  • Test CPT2, PYGM, ACADM, AMPD1, and VLCAD genes for metabolic myopathies causing recurrent rhabdomyolysis 1
  • Persistently elevated CK (idiopathic hyperCKemia) after full neurological evaluation requires further investigation 1

Renal Replacement Therapy

  • Determine need for renal replacement therapy on a case-by-case basis for severe acute kidney injury, refractory hyperkalemia, severe metabolic acidosis, or volume overload 3, 8, 6

Disposition

  • Most patients require hospital admission for aggressive fluid resuscitation and monitoring 3, 6
  • Admission is mandatory for patients with CK >15,000 IU/L, any degree of renal dysfunction, significant electrolyte abnormalities, or inability to maintain adequate oral hydration 2, 6

References

Guideline

Rhabdomyolysis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rhabdomyolysis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Rhabdomyolysis with Rash Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The other medical causes of rhabdomyolysis.

The American journal of the medical sciences, 2003

Research

, , RHABDOMYOLYSIS - INDUCED ACUTE KIDNEY INJURY - AN UNDERESTIMATED PROBLEM.

Wiadomosci lekarskie (Warsaw, Poland : 1960), 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.